(To Prospectus Dated April 14, 2026)
| | | |
Page
|
| |||
| Prospectus Supplement | | | | | | | |
| | | | | S-ii | | | |
| | | | | S-ii | | | |
| | | | | S-iii | | | |
| | | | | S-iv | | | |
| | | | | S-1 | | | |
| | | | | S-4 | | | |
| | | | | S-6 | | | |
| | | | | S-9 | | | |
| | | | | S-14 | | | |
| | | | | S-15 | | | |
| | | | | S-16 | | | |
| | | | | S-19 | | | |
| | | | | S-26 | | | |
| | | | | S-29 | | | |
| | | | | S-29 | | | |
| | | | | | 1 | | | |
| | | | | | 1 | | | |
| | | | | | 3 | | | |
| | | | | | 4 | | | |
| | | | | | 6 | | | |
| | | | | | 7 | | | |
| | | | | | 12 | | | |
| | | | | | 13 | | | |
| | | | | | 16 | | | |
| | | | | | 17 | | | |
| | | | | | 17 | | |
| | | |
Quarter Ended
March 31, 2026 |
| |||||||||
| | | |
Low
|
| |
High
|
| ||||||
| | | |
(in thousands)
|
| |||||||||
| Statement of Operations Data: | | | | | | | | | | | | | |
|
Revenue
|
| | | $ | 280,000 | | | | | $ | 284,000 | | |
|
Loss from operations
|
| | | $ | (985,000) | | | | | $ | (1,005,000) | | |
| Balance Sheet Data: | | | | | | | | | | | | | |
|
Cash and cash equivalents (at end of period)
|
| | | $ | 700,356 | | | | | $ | 700,356 | | |
|
Long-term debt (at end of period)
|
| | | $ | 2,047,844 | | | | | $ | 2,047,844 | | |
| | | |
Fiscal Years Ended December 31,
|
| |||||||||||||||
| | | |
2025
|
| |
2024
|
| |
2023
|
| |||||||||
| | | |
(in thousands, except share and per share numbers)
|
| |||||||||||||||
|
Revenue
|
| | | $ | 1,353,790 | | | | | $ | 807,832 | | | | | $ | 595,271 | | |
| Costs and expenses(1) | | | | | | | | | | | | | | | | | | | |
|
Cost of revenue
|
| | | | 2,610,176 | | | | | | 1,730,943 | | | | | | 1,936,066 | | |
|
Research and development
|
| | | | 1,211,397 | | | | | | 1,176,453 | | | | | | 937,012 | | |
|
Selling, general and administrative
|
| | | | 1,033,970 | | | | | | 900,952 | | | | | | 797,235 | | |
|
Restructuring charges
|
| | | | — | | | | | | 20,304 | | | | | | 24,546 | | |
|
Total cost and expenses
|
| | | | 4,855,543 | | | | | | 3,828,652 | | | | | | 3,694,859 | | |
|
Loss from operations
|
| | | | (3,501,753) | | | | | | (3,020,820) | | | | | | (3,099,588) | | |
| Other income (expense), net | | | | | | | | | | | | | | | | | | | |
|
Change in fair value of common stock warrant liability
|
| | | | 19,514 | | | | | | 34,150 | | | | | | 86,926 | | |
|
Change in fair value of equity securities of a related party
|
| | | | (15,785) | | | | | | (43,057) | | | | | | 5,999 | | |
|
Change in fair value of derivative liability associated with redeemable convertible preferred stock (related party)
|
| | | | 623,225 | | | | | | 155,350 | | | | | | — | | |
|
Gain on extinguishment of debt
|
| | | | 121,765 | | | | | | — | | | | | | — | | |
|
Interest income
|
| | | | 156,443 | | | | | | 213,026 | | | | | | 204,274 | | |
|
Interest expense
|
| | | | (95,101) | | | | | | (32,923) | | | | | | (24,915) | | |
|
Other income (expense), net
|
| | | | (8,692) | | | | | | (18,469) | | | | | | (90) | | |
|
Total other income, net
|
| | | | 801,369 | | | | | | 308,077 | | | | | | 272,194 | | |
|
Loss before provision for (benefit from) income taxes
|
| | | | (2,700,384) | | | | | | (2,712,743) | | | | | | (2,827,394) | | |
|
Provision for (benefit from) income taxes
|
| | | | (2,333) | | | | | | 1,199 | | | | | | 1,026 | | |
|
Net loss
|
| | | | (2,698,051) | | | | | | (2,713,942) | | | | | | (2,828,420) | | |
|
Accretion of redeemable convertible preferred stock (related party)
|
| | | | (983,648) | | | | | | (347,610) | | | | | | — | | |
|
Net loss attributable to common stockholders, basic
|
| | | | (3,681,699) | | | | | | (3,061,552) | | | | | | (2,828,420) | | |
|
Interest expense on 2026 Notes
|
| | | | 14,309 | | | | | | — | | | | | | — | | |
|
Gain on extinguishment of debt
|
| | | | (121,765) | | | | | | — | | | | | | — | | |
|
Net loss attributable to common stockholders, diluted
|
| | | $ | (3,789,155) | | | | | $ | (3,061,552) | | | | | $ | (2,828,420) | | |
| | | |
Fiscal Years Ended December 31,
|
| |||||||||||||||
| | | |
2025
|
| |
2024
|
| |
2023
|
| |||||||||
| | | |
(in thousands, except share and per share numbers)
|
| |||||||||||||||
|
Weighted average shares outstanding attributable to common stockholders, basic
|
| | | | 311,680,046 | | | | | | 244,517,654 | | | | | | 208,177,262 | | |
|
Weighted average shares outstanding attributable to common stockholders, diluted
|
| | | | 313,400,136 | | | | | | 244,517,654 | | | | | | 208,177,262 | | |
|
Net loss per share attributable to common stockholders, basic
|
| | | $ | (11.81) | | | | | $ | (12.52) | | | | | $ | (13.59) | | |
|
Net loss per share attributable to common stockholders, diluted
|
| | | $ | (12.09) | | | | | $ | (12.52) | | | | | $ | (13.59) | | |
| Other comprehensive income (loss) | | | | | | | | | | | | | | | | | | | |
|
Net unrealized gains on investments, net of tax
|
| | | $ | 3,860 | | | | | $ | 1,942 | | | | | $ | 12,669 | | |
|
Foreign currency translation adjustments
|
| | | | 9,931 | | | | | | (8,891) | | | | | | 3,753 | | |
|
Total other comprehensive income (loss)
|
| | | | 13,791 | | | | | | (6,949) | | | | | | 16,422 | | |
|
Comprehensive loss
|
| | | | (2,684,260) | | | | | | (2,720,891) | | | | | | (2,811,998) | | |
|
Accretion of redeemable convertible preferred stock (related party)
|
| | | | (983,648) | | | | | | (347,610) | | | | | | — | | |
|
Comprehensive loss attributable to common stockholders
|
| | | $ | (3,667,908) | | | | | $ | (3,068,501) | | | | | $ | (2,811,998) | | |
| | |||||||||||||||||||
| | | |
Fiscal Years Ended December 31,
|
| |||||||||||||||
| | | |
2025
|
| |
2024
|
| |
2023
|
| |||||||||
| | | |
(in thousands)
|
| |||||||||||||||
|
Cost of revenue
|
| | | $ | 3,325 | | | | | $ | 4,335 | | | | | $ | 3,590 | | |
|
Research and development
|
| | | | 183,770 | | | | | | 172,190 | | | | | | 137,703 | | |
|
Selling, general and administrative
|
| | | | 84,180 | | | | | | 110,827 | | | | | | 117,433 | | |
|
Restructuring charges
|
| | | | — | | | | | | (1,480) | | | | | | (1,443) | | |
|
Total
|
| | | $ | 271,275 | | | | | $ | 285,872 | | | | | $ | 257,283 | | |
| | | |
Fiscal Years Ended
December 31, |
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
| | | |
(in thousands)
|
| |||||||||
| Assets | | | | | | | | | | | | | |
|
Cash and cash equivalents
|
| | | $ | 997,827 | | | | | $ | 1,606,865 | | |
|
Total assets
|
| | | | 8,386,981 | | | | | | 9,647,931 | | |
| Liabilities | | | | | | | | | | | | | |
|
Debt, net of current portion
|
| | | | 2,046,576 | | | | | | 2,002,151 | | |
|
Common stock warrant liability
|
| | | | — | | | | | | 19,514 | | |
|
Total liabilities
|
| | | | 5,386,204 | | | | | | 4,475,277 | | |
| Redeemable Convertible Preferred Stock | | | | | | | | | | | | | |
|
Series A redeemable convertible preferred stock
|
| | | | 1,339,641 | | | | | | 730,025 | | |
|
Series B redeemable convertible preferred stock
|
| | | | 943,849 | | | | | | 569,817 | | |
| | | |
Fiscal Years Ended
December 31, |
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
| | | |
(in thousands)
|
| |||||||||
| Stockholders’ Equity | | | | | | | | | | | | | |
|
Common stock
|
| | | | 33 | | | | | | 30 | | |
|
Additional paid-in capital
|
| | | | 16,337,023 | | | | | | 16,808,291 | | |
|
Accumulated deficit
|
| | | | (15,610,745) | | | | | | (12,912,694) | | |
|
Total stockholders’ equity
|
| | | $ | 717,287 | | | | | $ | 3,872,812 | | |
| | |||||||||||||
| | | |
As of December 31, 2025
|
| |||||||||||||||
| | | |
Actual
|
| |
As Adjusted
|
| |
As Further
Adjusted |
| |||||||||
| | | |
(in millions, except for share and
per share amounts and footnotes) |
| |||||||||||||||
|
Cash, cash equivalents and short-term investments
|
| | | $ | 1,628.9 | | | | | $ | 2,878.9 | | | | | $ | 3,170.5 | | |
| Debt (including current portion): | | | | | | | | | | | | | | | | | | | |
|
2026 Convertible Notes(1)
|
| | | | 204.3 | | | | | | 204.3 | | | | | | 204.3 | | |
|
2030 Convertible Notes(2)
|
| | | | 1,100.0 | | | | | | 1,100.0 | | | | | | 1,100.0 | | |
|
2031 Convertible Notes(3)
|
| | | | 975.0 | | | | | | 975.0 | | | | | | 975.0 | | |
|
ABL Credit Facility(4)
|
| | | | — | | | | | | — | | | | | | — | | |
|
GIB Credit Facility(5)
|
| | | | 468.0 | | | | | | 468.0 | | | | | | 468.0 | | |
|
DDTL Credit Facility(6)
|
| | | | — | | | | | | 500.0 | | | | | | 500.0 | | |
|
SIDF Loan(7)
|
| | | | — | | | | | | — | | | | | | — | | |
|
Total debt
|
| | | | 2,747.3 | | | | | | 3,247.3 | | | | | | 3,247.3 | | |
| Redeemable Convertible Preferred Stock: | | | | | | | | | | | | | | | | | | | |
|
Preferred stock, 10,000,000 shares authorized, actual, as adjusted and
as further adjusted, Series A redeemable convertible preferred stock, $0.0001 par value per share; 100,000 shares issued and outstanding, actual, as adjusted and as further adjusted (related party)(8) |
| | | | 1,339.6 | | | | | | 1,339.6 | | | | | | 1,339.6 | | |
|
Preferred stock, 10,000,000 shares authorized, actual, as adjusted and
as further adjusted, Series B redeemable convertible preferred stock, $0.0001 par value per share; 75,000 shares issued and outstanding, actual, as adjusted and as further adjusted (related party)(9) |
| | | | 943.8 | | | | | | 943.8 | | | | | | 943.8 | | |
|
Preferred stock, 10,000,000 shares authorized, actual, as adjusted and
as further adjusted, Series C redeemable convertible preferred stock, $0.0001 par value per share; 0 share issued and outstanding, actual; 55,000 shares issued and outstanding, as adjusted; 55,000 shares issued and outstanding, as further adjusted (related party)(10) |
| | | | — | | | | | | 550.0 | | | | | | 550.0 | | |
|
Total redeemable convertible preferred stock
|
| | | | 2,283.5 | | | | | | 2,833.5 | | | | | | 2,833.5 | | |
| | | |
As of December 31, 2025
|
| |||||||||||||||
| | | |
Actual
|
| |
As Adjusted
|
| |
As Further
Adjusted |
| |||||||||
| | | |
(in millions, except for share and
per share amounts and footnotes) |
| |||||||||||||||
| Stockholders’ equity: | | | | | | | | | | | | | | | | | | | |
|
Common stock, $0.0001 par value per share; 1,500,000,000 shares
authorized, actual, as adjusted and as further adjusted; 327,451,844 shares issued and 327,366,062 shares outstanding, actual; 351,490,306 shares issued and 351,404,524 shares outstanding, as adjusted; 387,547,998 shares issued and 387,462,216 shares outstanding, as further adjusted;(11) |
| | | | 0.033 | | | | | | 0.035 | | | | | | 0.039 | | |
|
Additional paid-in capital
|
| | | | 16,337.0 | | | | | | 16,537.0 | | | | | | 16,828.6 | | |
|
Accumulated deficit
|
| | | | (15,610.7) | | | | | | (15,610.7) | | | | | | (15,610.7) | | |
|
Total stockholders’ equity
|
| | | | 717.3 | | | | | | 917.3 | | | | | | 1,208.8 | | |
|
Total capitalization
|
| | | $ | 5,748.1 | | | | | $ | 6,998.1 | | | | | $ | 7,289.6 | | |
| | |||||||||||||||||||
| | | |
Page
|
| |||
| | | | | 1 | | | |
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 12 | | | |
| | | | | 13 | | | |
| | | | | 16 | | | |
| | | | | 17 | | | |
| | | | | 17 | | | |